305 related articles for article (PubMed ID: 1511537)
1. Pharmacokinetic optimisation of anticonvulsant therapy.
Thomson AH; Brodie MJ
Clin Pharmacokinet; 1992 Sep; 23(3):216-30. PubMed ID: 1511537
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part II. Phenytoin, carbamazepine, sulthiame, lamotrigine, vigabatrin, oxcarbazepine and felbamate.
Battino D; Estienne M; Avanzini G
Clin Pharmacokinet; 1995 Nov; 29(5):341-69. PubMed ID: 8582119
[TBL] [Abstract][Full Text] [Related]
3. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Perucca E; Cloyd J; Critchley D; Fuseau E
Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
[TBL] [Abstract][Full Text] [Related]
4. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability.
Alvarez N; Besag F; Iivanainen M
J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():1-15. PubMed ID: 10030426
[TBL] [Abstract][Full Text] [Related]
5. Harnessing the clinical potential of antiepileptic drug therapy: dosage optimisation.
Perucca E; Dulac O; Shorvon S; Tomson T
CNS Drugs; 2001; 15(8):609-21. PubMed ID: 11524033
[TBL] [Abstract][Full Text] [Related]
6. A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation.
Ding J; Wang Y; Lin W; Wang C; Zhao L; Li X; Zhao Z; Miao L; Jiao Z
Clin Pharmacokinet; 2015 Mar; 54(3):305-17. PubMed ID: 25388986
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic interactions of the new antiepileptic drugs.
Rambeck B; Specht U; Wolf P
Clin Pharmacokinet; 1996 Oct; 31(4):309-24. PubMed ID: 8896946
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations.
Riva R; Albani F; Contin M; Baruzzi A
Clin Pharmacokinet; 1996 Dec; 31(6):470-93. PubMed ID: 8968658
[TBL] [Abstract][Full Text] [Related]
9. Vigabatrin. Clinical pharmacokinetics.
Rey E; Pons G; Olive G
Clin Pharmacokinet; 1992 Oct; 23(4):267-78. PubMed ID: 1395360
[TBL] [Abstract][Full Text] [Related]
10. The effects of co-medications on lamotrigine clearance in Japanese children with epilepsy.
Takeuchi T; Natsume J; Kidokoro H; Ishihara N; Yamamoto H; Azuma Y; Ito Y; Kurahashi N; Tsuji T; Suzuki M; Itomi K; Yamada K; Kurahashi H; Abe S; Okumura A; Maruyama K; Negoro T; Watanabe K; Kojima S
Brain Dev; 2016 Sep; 38(8):723-30. PubMed ID: 27033151
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication.
Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI
Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154
[TBL] [Abstract][Full Text] [Related]
12. Steady-state pharmacokinetic simulation of intermittent vs. continuous infusion valproic acid therapy in non-critically ill and critically ill patients.
Van Matre ET; Cook AM
Neurol Res; 2016 Sep; 38(9):786-91. PubMed ID: 27414414
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of antiepileptic medication: newborn to elderly.
Leppik IE
Epilepsia; 1992; 33 Suppl 4():S32-40. PubMed ID: 1425492
[TBL] [Abstract][Full Text] [Related]
14. Lacosamide serum concentrations in adult patients with epilepsy: the influence of gender, age, dose, and concomitant antiepileptic drugs.
Markoula S; Teotonio R; Ratnaraj N; Duncan JS; Sander JW; Patsalos PN
Ther Drug Monit; 2014 Aug; 36(4):494-8. PubMed ID: 24562047
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetic modelling of carbamazepine in epileptic elderly patients: implications for dosage.
Bondareva IB; Jelliffe RW; Gusev EI; Guekht AB; Melikyan EG; Belousov YB
J Clin Pharm Ther; 2006 Jun; 31(3):211-21. PubMed ID: 16789986
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacokinetics of anticonvulsants.
Hvidberg EF; Dam M
Clin Pharmacokinet; 1976; 1(3):161-88. PubMed ID: 797496
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part I: Phenobarbital, primidone, valproic acid, ethosuximide and mesuximide.
Battino D; Estienne M; Avanzini G
Clin Pharmacokinet; 1995 Oct; 29(4):257-86. PubMed ID: 8549027
[TBL] [Abstract][Full Text] [Related]
18. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F;
Lancet Neurol; 2011 Jul; 10(7):609-17. PubMed ID: 21652013
[TBL] [Abstract][Full Text] [Related]
19. Impact of age, weight and concomitant treatment on lamotrigine pharmacokinetics.
Brzaković BB; Vezmar Kovačević SD; Vučićević KM; Miljković BR; Martinović ZJ; Pokrajac MV; Prostran MŠ
J Clin Pharm Ther; 2012 Dec; 37(6):693-7. PubMed ID: 22583007
[TBL] [Abstract][Full Text] [Related]
20. A comparative review of the adverse effects of anticonvulsants in children with epilepsy.
Wallace SJ
Drug Saf; 1996 Dec; 15(6):378-93. PubMed ID: 8968693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
